Apollo Endosurgery Inc
NASDAQ:APEN
Balance Sheet
Balance Sheet Decomposition
Apollo Endosurgery Inc
Current Assets | 92.9m |
Cash & Short-Term Investments | 57m |
Receivables | 15m |
Other Current Assets | 20.9m |
Non-Current Assets | 17.4m |
PP&E | 7.5m |
Intangibles | 8.4m |
Other Non-Current Assets | 1.4m |
Current Liabilities | 39.5m |
Accounts Payable | 7.4m |
Accrued Liabilities | 12.4m |
Other Current Liabilities | 19.7m |
Non-Current Liabilities | 38.1m |
Long-Term Debt | 34m |
Other Non-Current Liabilities | 4.1m |
Balance Sheet
Apollo Endosurgery Inc
Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
12
|
17
|
22
|
19
|
31
|
24
|
30
|
36
|
91
|
57
|
|
Cash Equivalents |
12
|
17
|
22
|
19
|
31
|
24
|
30
|
36
|
91
|
57
|
|
Total Receivables |
1
|
1
|
11
|
11
|
12
|
11
|
9
|
8
|
10
|
15
|
|
Accounts Receivables |
1
|
1
|
11
|
11
|
12
|
11
|
9
|
8
|
10
|
15
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
13
|
12
|
14
|
10
|
9
|
10
|
12
|
18
|
|
Other Current Assets |
0
|
0
|
2
|
2
|
1
|
3
|
3
|
4
|
2
|
3
|
|
Total Current Assets |
14
|
18
|
47
|
44
|
58
|
48
|
51
|
59
|
115
|
93
|
|
PP&E Net |
0
|
0
|
8
|
7
|
7
|
6
|
7
|
6
|
6
|
8
|
|
PP&E Gross |
0
|
0
|
8
|
7
|
7
|
6
|
7
|
6
|
6
|
8
|
|
Accumulated Depreciation |
1
|
1
|
4
|
4
|
7
|
7
|
9
|
11
|
11
|
12
|
|
Intangible Assets |
2
|
2
|
49
|
43
|
36
|
10
|
8
|
6
|
4
|
3
|
|
Goodwill |
0
|
0
|
0
|
7
|
7
|
5
|
5
|
5
|
5
|
5
|
|
Other Long-Term Assets |
0
|
0
|
1
|
2
|
1
|
5
|
4
|
1
|
2
|
1
|
|
Other Assets |
0
|
0
|
0
|
7
|
7
|
5
|
5
|
5
|
5
|
5
|
|
Total Assets |
16
N/A
|
21
+34%
|
105
+401%
|
102
-3%
|
109
+7%
|
75
-32%
|
75
+0%
|
77
+4%
|
132
+70%
|
110
-16%
|
|
Liabilities | |||||||||||
Accounts Payable |
2
|
3
|
5
|
5
|
18
|
15
|
10
|
4
|
5
|
7
|
|
Accrued Liabilities |
1
|
1
|
6
|
6
|
8
|
9
|
7
|
7
|
10
|
12
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
34
|
1
|
0
|
20
|
|
Other Current Liabilities |
1
|
0
|
10
|
9
|
0
|
0
|
2
|
0
|
0
|
0
|
|
Total Current Liabilities |
4
|
4
|
21
|
20
|
26
|
24
|
53
|
12
|
14
|
40
|
|
Long-Term Debt |
0
|
0
|
70
|
39
|
33
|
21
|
19
|
57
|
53
|
34
|
|
Other Liabilities |
2
|
1
|
3
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
|
Total Liabilities |
6
N/A
|
5
-11%
|
94
+1 743%
|
60
-36%
|
59
-1%
|
46
-23%
|
73
+59%
|
71
-2%
|
70
-1%
|
78
+10%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
145
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
50
|
66
|
109
|
150
|
177
|
223
|
250
|
273
|
297
|
337
|
|
Additional Paid In Capital |
59
|
82
|
25
|
191
|
225
|
249
|
251
|
277
|
357
|
365
|
|
Other Equity |
0
|
0
|
0
|
2
|
2
|
3
|
2
|
3
|
2
|
5
|
|
Total Equity |
10
N/A
|
16
+58%
|
11
-29%
|
42
+279%
|
50
+18%
|
29
-42%
|
2
-93%
|
7
+224%
|
61
+801%
|
33
-47%
|
|
Total Liabilities & Equity |
16
N/A
|
21
+34%
|
105
+401%
|
102
-3%
|
109
+7%
|
75
-32%
|
75
+0%
|
77
+4%
|
132
+70%
|
110
-16%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
0
|
0
|
1
|
11
|
17
|
22
|
21
|
26
|
40
|
42
|
|
Preferred Shares Outstanding |
0
|
0
|
93
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|